section name header

Y-Site Injection Compatibility (1:1 Mixture)

Idarubicin HCl

(Mfr: AD)(Conc: 1 mg/mLb)

I

Clindamycin phosphate

(Mfr: AST)(Conc: 12 mg/mLa)

Remarks:

Haze and precipitate form immediately

Ref:

1525